Inventor
ANDRE PASCALE
FR18 patents
⚠️ This page may combine multiple inventors who share the name “ANDRE PASCALE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNATE PHARMA
7 patentsUS10329348B2Jun 25, 2019
Treatment of cancers using anti-NKG2A agents
INNATE PHARMA16 citations92
US10711063B2Jul 14, 2020
Neutralization of inhibitory pathways in lymphocytes
INNATE PHARMA8 citations83
US10676523B2Jun 9, 2020
Treatment regimens using anti-NKG2A antibodies
INNATE PHARMA7 citations80
US11572410B2Feb 7, 2023
Neutralization of inhibitory pathways in lymphocytes
INNATE PHARMA3 citations72
US11225519B2Jan 18, 2022
Treatment of cancers using anti-NKG2A agents
INNATE PHARMA3 citations71
US10870700B2Dec 22, 2020
Neutralization of inhibitory pathways in lymphocytes
INNATE PHARMA6 citations69
US12037392B2Jul 16, 2024
Treatment regimens using anti-NKG2A antibodies
INNATE PHARMA0 citations59
MORETTA ALESSANDRO
3 patentsBRISTOL MYERS SQUIBB CO
3 patentsUS9789182B2Oct 17, 2017
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
BRISTOL MYERS SQUIBB CO11 citations81
US10688180B2Jun 23, 2020
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
BRISTOL MYERS SQUIBB CO2 citations70
US10494433B2Dec 3, 2019
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma
BRISTOL MYERS SQUIBB CO1 citations56